Inotiv
CLOSE ×
[Safety Assessment, IBD, Crohn's, Colitis, Endoscopy]

Advantages of Non-Remitting Chronic IBD Models

The Advantages of Non-Remitting Chronic IBD Rodent ModelsAs the frequency of inflammatory bowel disease (IBD) increases globally, preclinical researchers continue to study new treatments that can...

[Animal welfare, Surgical models, Research services, Research models, Telemetry, Surgical Services]

Promoting Animal Welfare with Implanted Telemetry

As part of the advanced surgical services offered by Inotiv, telemetry represents an important part of a thoughtful, experimental design. Learn how telemetered data can promote animal welfare,...

[]

A Consultative Approach to Deliver Excellent Client Experiences

Helping clients realize the full potential of their critical R&D projects starts with a trusted partnership. From research models to specialized services, our team at Envigo–an Inotiv company,...

[]

The Facts About Fiber and Other Key Ingredients in Your Laboratory Rodent Diet

When considering the fiber and nutrient content of laboratory diet for your rodents, it is important to understand the differences between a natural ingredient diet and a purified diet. Fiber in...

[]

Maintaining and Reporting Health Status of Zebrafish with Diagnostic Testing

Zebrafish (Danio rerio) are considered a unique model for biomedical research given their genomic and molecular similarities to vertebrates. As use of zebrafish as a model of disease increases,...

[]

Examining the Tumor Microenvironment with Patient-Derived Xenografts (PDX)

Examining the tumor microenvironment with patient-derived xenografts (PDX)

[]

Advancing therapeutic research for long COVID with an enhanced hACE2 mouse model

Envigo, an Inotiv company, is leading the charge to advance therapeutic research for long COVID with an enhanced hACE2 mouse model.

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now